This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug PRIORIX contains one active pharmaceutical ingredient (API):
| 1 Measles, live attenuated |
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BD52 | Measles, combinations with mumps and rubella, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BD Measles vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510605701155312, 510618090060307 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02239208 |
| Country: EE | Ravimiamet | Identifier(s): 1039340, 1066137, 1611548, 1611559, 1611560, 1611571, 1611582, 1611593, 1611605, 1611616, 1611627, 1611638 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 62314 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 390034, 405597 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61896473 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 349254 |
| Country: HK | Department of Health Drug Office | Identifier(s): 43861 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-788122655 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4146 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1017850, 1017851, 1017852, 1017853, 1024863, 1024865, 1070891, 1070892, 1070893, 1070894, 1070949, 1070950, 1070951, 1070952, 1070953, 1070954, 1070955, 1070956, 1088535 |
| Country: MT | Medicines Authority | Identifier(s): MA170/01301, MA170/01302, PI1438/02001A, PI770/16501A |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 8110 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100224251 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W58947005, W58947006, W58947007, W58947008, W58947009, W58947010, W58947011, W58947012, W58947013, W58947014, W58947015, W58947016, W58947017, W58947018, W58947019, W58947020, W58947021, W58947022, W58947023, W58947024 |
| Country: SG | Health Sciences Authority | Identifier(s): 10822P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7063111 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522964215, 8699522964222, 8699522964239, 8699522964246, 8699522967469 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 33/30.1/0346 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
